RCAT Insider Vesting: 262,500 RSUs Convert; Sale of 89,838 Shares
Rhea-AI Filing Summary
Geoffrey Hitchcock, Chief Revenue Officer of Red Cat Holdings, Inc. (RCAT), reported changes in his holdings on a Form 4. On 10/01/2025 he was credited with 262,500 restricted stock units (RSUs) that convert one-for-one into common stock; those RSUs reflect the first half of a 525,000 RSU grant originally awarded on 11/24/2024 and vesting in equal installments on 10/01/2025 and 10/01/2026. The filing shows a sale of 89,838 shares at $10.47 each on the same date. After these transactions, the reporting person’s disclosed beneficial ownership of common stock is 204,987 shares
Positive
- 262,500 RSUs vested on 10/01/2025, converting one-for-one into common stock
- RSU grant was part of a 525,000 award with clear vesting schedule (10/01/2025 and 10/01/2026)
Negative
- Sale of 89,838 shares at $10.47 on 10/01/2025 reduced direct holdings to 204,987 shares
- Filing indicates prior reports aggregated derivatives and shares and will be amended, requiring clarification of historic ownership disclosures
Insights
Insider received RSUs and sold a portion of shares on 10/01/2025.
The report documents a 262,500 RSU vesting event that converts to 262,500 shares one-for-one; this is the first installment of a 525,000 grant dated 11/24/2024. Simultaneously, the filing discloses a sale of 89,838 shares at $10.47 per share on 10/01/2025, reducing the reporting person’s direct share count to 204,987.
These actions are routine compensation realization and liquidity events by an executive; the filing also notes the reporting person will amend prior reports to separate non-derivative and derivative counts.
RSU vesting aligns with scheduled compensation; sale appears to be partial monetization.
The 525,000 RSU award vests in two equal installments on 10/01/2025 and 10/01/2026, with 262,500 units vesting on the first date. The sale of 89,838 shares at $10.47 likely represents partial proceeds from the vesting event or existing holdings being cashed out. No new derivative grants, option exercises, or other compensatory changes are disclosed in this Form 4.